SeaSpine Holdings

SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CARLSBAD, Calif., May  01, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming STRH Life Sciences Summit Virtual Series.

SeaSpine to Present at the SunTrust Robinson Humphrey (STRH) Life Sciences Summit Virtual Meeting Series

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

SeaSpine Holdings has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

SeaSpine Holdings Enters Oversold Territory

Strong Cash Position of Approximately $105 Million Provides Operational Stability  

SeaSpine Provides Preliminary Results for First Quarter 2020 and COVID-19 Related Business Update

SeaSpine Holdings has been struggling lately, but the selling pressure may be coming to an end soon.

SeaSpine Sees Hammer Chart Pattern: Time to Buy?

SeaSpine Holdings' (SPNE) CEO Keith Valentine on Q4 2019 Results - Earnings Call Transcript

CARLSBAD, Calif. and TORONTO, Feb.  07, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, and 7D Surgical, Inc., a privately-held Toronto-based company developing advanced image guidance technologies and machine-vision-based registration algorithms to improve surgical workflow and patient care, today announced that they have entered into a strategic alliance agreement.  Financial terms were not disclosed.

SeaSpine® and 7D Surgical Announce Entry into a Strategic Alliance Agreement to Distribute 7D Surgical’s Flagship Machine-Vision Image Guided Surgery (MvIGS) Platform

CARLSBAD, Calif., Feb.  03, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to eight non-executive employees.

SeaSpine Reports Granting  of Inducement Awards

SeaSpine Holdings Corporation (SPNE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: SeaSpine

Provides Revenue Guidance for 2020 Provides Revenue Guidance for 2020

SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2019; Reports Record Revenue, Driven by Greater Than 20% U.S. Spinal Implants Growth

CARLSBAD, Calif., Dec.  30, 2019  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Mariner® Midline Posterior Fixation System.

SeaSpine Announces Full Commercial Launch of  Mariner® Midline Posterior Fixation System

CARLSBAD, Calif., Dec.  18, 2019  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the implantation of the 25,000th NanoMetalene® interbody device.

SeaSpine Announces 25,000th NanoMetalene® Implantation

SeaSpine Holdings Corporation (SPNE) CEO Keith Valentine on Q3 2019 Results - Earnings Call Transcript

Increases 2019 total revenue guidance to between $157 million and $158 million  Implies 10% to 12% growth over fourth quarter 2018

SeaSpine Reports Record Revenue, Driven by 16% U.S. Spinal Implants Growth

CARLSBAD, Calif., Sept.  24, 2019  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has entered into an exclusive (field-based) development and licensing agreement with restor3d, Inc., a privately-held medical device company co-founded by Ken Gall, Professor of Mechanical Engineering at Duke University, that specializes in developing 3D-printed implants with enhanced anatomical fit and superior integrative properties.  Financial terms were not disclosed.

SeaSpine® Announces Exclusive Development and Licensing Agreement with restor3D®

CARLSBAD, Calif., Sept.  23, 2019  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming Cantor Global Healthcare Conference in New York.

SeaSpine to Present at the Cantor Global Healthcare Conference

CARLSBAD, Calif., Sept.  12, 2019  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will host an Analyst & Investor Event in Chicago, Illinois on Thursday, September 26 from 7:30 a.m. to 9:00 a.m. Central Time.

SeaSpine to Host Analyst & Investor Event on September 26, 2019

CARLSBAD, Calif., Sept.  10, 2019  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming 2019 Ladenburg Thalmann Healthcare Conference in New York.

SeaSpine to Present at the Ladenburg Thalmann 2019 Healthcare Conference

CARLSBAD, Calif., Aug.  28, 2019  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming 14th Annual Wells Fargo Healthcare Conference in Boston.

SeaSpine to Present at the 14th Annual Wells Fargo Healthcare Conference

SeaSpine Holdings' (SPNE) CEO Keith Valentine on Q2 2019 Results - Earnings Call Transcript

SeaSpine Holdings Corporation (SPNE) CEO Keith Valentine on Q1 2019 Results - Earnings Call Transcript

News for SeaSpine Holdings Stock (SPNE)